Plane Warts
Conditions
Keywords
ivermectin
Brief summary
This study aims to evaluate the efficacy of ivermectin in the treatment of plane warts( flat warts). patients diagnosed with plane warts will be included to assess the clearance ratre of the lesions.
Interventions
DRUGIvermectin
An antiparasitic medication evaluated for its immunomodulatory and antiviral efficacy in clearing plane warts. it will be administered to patients according to their assigned group protocol.
OTHERPlacebo
Patients in the control group will receive placebo,they will undergo standard clinical observation and follow up to monitor the natural course of the plane warts.
Sponsors
Al-Azhar University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
5 Years to No maximum
Healthy volunteers
No
Inclusion criteria
• Clinical and dermoscopic diagnosis of the plane warts. * No prior treatment for warts in the last 4 weeks. * Patients of both sex (male - female) * Age more than 5 years or weight more than 15 kg.
Exclusion criteria
* • Patients with other types of warts (e.g., common, plantar, genital). * History of hypersensitivity or allergy to ivermectin or its components. * Patients who have received systemic immunosuppressive therapy within the last 3 months. * Presence of chronic skin conditions that may interfere with evaluation (e.g., eczema, psoriasis). * Patients with immunodeficiency disorders (e.g., HIV, organ transplant recipients). * Pregnant or lactating females. * Patients currently on systemic antiviral or immunomodulatory treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| percentage of patients achieving complete clearance of plane warts | 3 months |
Countries
Egypt
Outcome results
None listed